Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 258

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 258
---
 transactions contemplated by the Merger Agreement or the announcement, pendency or anticipated consummation of the transactions contemplated by the Merger Agreement; |

| • | any failure by Channel or any of its subsidiaries to meet any public estimates or expectations of its revenue, earnings or other financial performance or results of operations for any period; |

| • | any failure by Channel or any of its subsidiaries to meet any internal guidance, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations; |

| • | the taking of any action, or the failure to take any action, by LNHC that is expressly required under the terms of the Merger Agreement; |

| • | any changes in or affecting research and development, preclinical studies, clinical trials or other drug development activities (including the failure to obtain positive results from clinical trials, the occurrence of adverse events or serious adverse events in any clinical trial, development activities or favorable responses from any applicable governmental entity) conducted by or on behalf of Channel or any of its subsidiaries or licensees in respect of its products or product candidates; |

142

TABLE OF CONTENTS

| • | regulatory approval of, or regulatory action or announcement with respect to, any products, or product candidates, of a third party that are similar to, or expected to compete against, any of Channel’s or any of its subsidiaries’ product candidates, including product candidates licensed out to the third parties; |

| • | any stockholder or derivative litigation arising from or relating to the Merger Agreement or the transactions contemplated by the Merger Agreement; or |

| • | other specified matters therein. |

Termination Termination of the Merger Agreement The Merger Agreement may be terminated at any time before the Effective Time, whether before or (subject to the terms of the Merger Agreement) after the required stockholder approvals to complete the Merger have been obtained, as set forth below:

| (a) | by mutual written consent of Channel and LNHC; |

| (c) | by either Channel or LNHC, if a governmental entity of competent jurisdiction has issued a nonappealable final order, decree or ruling or taken any other nonappealable final action that permanently restrains, enjoins or otherwise prohibits the Merger; provided, that this right to terminate the Merger Agreement will not be available to any party if the issuance of any such order, decree, ruling or other action is principally attributable to the failure of such party, or any affiliate of such party, to perform